This site is intended for healthcare professionals only
LoginRegister
Ciplas Lanreotide Supply Partners Greece Plant Gets USFDA OAI StatusCipla to futher invest up to Rs 26 crore in Achira Labs
Mankind Pharma Gets Relief as CGST Appellate Authority Drops Rs 1.02 Cr PenaltyMankind Pharma posts over 65 percent rise in Q4 profit
CDSCO Panel Clears Bristol Myers Yervoy for Two New Cancer IndicationsUSFDA grants accelerated approval for Bristol Myers Squibb CAR T Cell Therapy Breyanzi for Relapsed...
Alonzo Weems to retire as Executive Vice President of Enterprise Risk Management, Chief Ethics and Compliance Officer: Eli LillyAlonzo Weems to retire as Executive Vice President of Enterprise Risk Management, Chief Ethics and...
Lupin Receives USFDA EIR with VAI Status for Goa Manufacturing PlantLupin gets ISO 14001 and ISO 45001 certification across all its Indian manufacturing sites, RnD...
PCI issues Guidelines for Inspections of Pharmacy Institutions for academic year 2024- 2025PCI issues Guidelines for Inspections of Pharmacy Institutions for academic year 2024- 2025
USFDA Grants Tentative Approval, 180-Day Exclusivity to Granules Generic Amphetamine XRGranules India reports 1.6 percent fall in Q4 revenue
Zydus Wellness net sales up by 31 percent in Q2 FY26Zydus Wellness net sales up by 9.6 percent to Rs 778 crores in Q4
Roche Drops Muscle Disease Drug After Trial FailureUSFDA approves Roche HPV self-collection solution in US
Aurobindo Pharma arm to acquire 20% additional ownership in Luoxin Aurovitas for Rs 45 croreNovo Holdings to acquire majority stake in Single Use Support
Indian Pharma Market Kicks Off 2026 With 10% Growth in January: PharmaTracShares of Indegene listed with nearly 46 percent premium
Abbott India Hit With Rs 2.40 Cr GST Penalty Over Alleged ITC Disallowance, Plans AppealCDSCO Panel opins Abbott Healthcare to Conduct Phase III CT of Clarithromycin ER Tablets 1000mg
X